41
“... was to evaluate the acute toxic effects of shallomin and to estimate its lethal dose low (LDLo) value. MATERIALS...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
42
Por Badea, Cristian T., Hedlund, Laurence W., Qi, Yi, Berridge, Brian, Johnson, G. Allan
Publicado em 2011
“... (dose: 0.0875 mg). Multiple DSA sequences were acquired before, during, and up to 25 minutes after drug...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
43
Por Patel, Neha, Cook, Abigail, Greenhalgh, Elizabeth, Rech, Megan A, Rusinak, Joshua, Heinrich, Lynley
Publicado no World J Transplant (2016)
“... to as tacrolimus-BID) is an immunosuppressive agent to prevent and treat allograft rejection in kidney transplant...”Publicado no World J Transplant (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
44
“... use of this agent in area hospitals, we studied its use in a University teaching hospital. METHODS...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
45
Por Gursoy, Sinan, Bagcivan, Ihsan, Durmus, Nedim, Kaygusuz, Kenan, Kol, Iclal Ozdemir, Duger, Cevdet, Yildirim, Sahin, Mimaroglu, Caner
Publicado em 2011
“... heart rate in a dose-dependent manner compared with the control group (P < 0.027). Vecuronium...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
46
Por Sticozzi, C, Belmonte, G, Cervellati, F, Muresan, XM, Pessina, F, Lim, Y, Forman, HJ, Valacchi, G
Publicado em 2014
“...Cigarette smoking (CS) has been strongly linked to several health conditions including heart...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
47
“... and benefits from particular dosing regimens. The most frequently prescribed colonic cleansing agent...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
48
Por Katz, Guy, Khoury, Assad, Kurtzwald, Efrat, Hochhauser, Edith, Porat, Eyal, Shainberg, Asher, Seidman, Jonathan G., Seidman, Christine E., Lorber, Abraham, Eldar, Michael, Arad, Michael
Publicado em 2010
“... by calsequestrin (CASQ2) mutations. METHODS: Murine heart rhythm telemetry was obtained at rest, during treadmill...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
49
Por Flanagan, Shawn, McKee, Edward E., Das, Debaditya, Tulkens, Paul M., Hosako, Hiromi, Fiedler-Kelly, Jill, Passarell, Julie, Radovsky, Ann, Prokocimer, Philippe
Publicado no Antimicrob Agents Chemother (2014)
“... and pharmacokinetic assessments were conducted. In isolated rat heart mitochondria, tedizolid inhibited MPS more...”Publicado no Antimicrob Agents Chemother (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
50
Por Ahad, Abdul, Al-Jenoobi, Fahad I., Al-Mohizea, Abdullah M., Akhtar, Naseem, Raish, Mohammad, Aqil, Mohd.
Publicado no Saudi Pharm J (2015)
“... forms due to greater frequency of drug administration. Although there is availability of a plethora...”Publicado no Saudi Pharm J (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
51
“... contributed a very effective approach. However, many patients do not achieve, at the maximal tolerated dose...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
52
“... concerns of these agents have largely centered upon their potential to elicit reproductive...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
53
“... (ketofol), 2 min subsequent to injection of 0.25 mg/kg each. Sedation was maintained with additional doses...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
54
Por Moore, Charity G., Schenkman, Margaret, Kohrt, Wendy M., Delitto, Anthony, Hall, Deborah A., Corcos, Daniel
Publicado em 2013
“... is to be prescribed as “first-line” or “add-on” therapy in patients with PD, we must demonstrate its efficacy and dose...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
55
Por Karaaslan, Kazim, Yilmaz, Fahrettin, Gulcu, Nebahat, Colak, Cemil, Sereflican, Murat, Kocoglu, Hasan
Publicado em 2007
“... for comfort of both the patient and the surgeon. Several combinations with different agents have been used...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
56
“.... Local therapy also reduces the systemic dose and eliminates the toxic side effects of some drugs...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
57
Por Herttua, Kimmo, Tabák, Adam G., Martikainen, Pekka, Vahtera, Jussi, Kivimäki, Mika
Publicado em 2013
“... disease, 2144 died from stroke and 24 560 were hospitalized due to stroke during the follow-up. At the 2...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
58
“... agents with different affinities for ET-receptor subtypes (ET(A) and ET(B)), and the focus of development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
59
Por Binbrek, Azan S., Elis, Avishay, Al-Zaibag, Muayed, Eha, Jaan, Keber, Irena, Cuevas, Ada M., Mukherjee, Swati, Miller, Thomas R.
Publicado em 2006
“..., it is timely to confirm the efficacy of these agents in other patient populations in routine clinical practice...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
60
Por Moise, Nathalie, Schwartz, Joseph, Bring, Rachel, Shimbo, Daichi, Kronish, Ian M.
Publicado no Am J Hypertens (2015)
“... adherence to beta-blockers may have been due to the common practice of prescribing multiple daily dosing...”Publicado no Am J Hypertens (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo